What is IDXX stock price today?

IDXX (Idexx Laboratories Inc) stock is trading at $656.73 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is IDXX stock going up or down today?

IDXX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy IDXX stock now?

The decision to buy IDXX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is IDXX a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for IDXX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is IDXX stock overvalued or undervalued?

IDXX currently trades at a P/E ratio of 50.25, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if IDXX is fairly priced.

What is IDXX's P/E ratio?

IDXX has a price-to-earnings (P/E) ratio of 50.25, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is IDXX's market cap?

IDXX (Idexx Laboratories Inc) has a market capitalization of $52.54 billion, making it a mid-cap stock.

What is IDXX's price to book ratio?

IDXX trades at a price-to-book (P/B) ratio of 32.86, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does IDXX pay dividends?

IDXX does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is IDXX's dividend yield?

IDXX does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is IDXX stock a good long-term investment?

IDXX's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is IDXX's revenue growth rate?

IDXX has shown revenue growth of 0.1% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, IDXX is profitable with a profit margin of 0.2%. This indicates the company generates 0.2 cents of profit for every dollar of revenue.

What are the risks of investing in IDXX?

Key risks for IDXX include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does IDXX compare to its competitors?

Compare IDXX to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize IDXX's performance and positioning.

What is IDXX's stock price target for 2026?

Our AI model provides price targets for IDXX based on fundamental analysis: Bull case $853.75 (+30%), Base case $755.24 (+15%), Bear case $591.06 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about IDXX?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for IDXX. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is IDXX's next earnings report?

IDXX reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

IDXX - Idexx Laboratories Inc

NYSE * Health Care * Life Sciences Tools & Services

$656.73

$-3.98 (-0.60%)

About Idexx Laboratories Inc

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDXX Key Statistics

Market Cap

$52.54B

P/E Ratio

50.25

P/B Ratio

32.86

EPS

$13.07

Revenue Growth

+0.1%

Profit Margin

0.2%

Employees

11,000

How IDXX Compares to Peers

IDXX trades at a premium valuation vs peers (highest P/E)

IDXX has the highest profit margins in Life Sciences Tools & Services

IDXX has the fastest revenue growth among competitors

P/E Rank

of 2

Margin Rank

of 2

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
IDXX(This stock)	$52.54B	50.2	0%	0.2%	-
AMZNAmazon Com	$2.23T	29.0	0%	0.1%	vs AMZN

Idexx Laboratories Inc Company Information

Headquarters: Maine; U.S.A
Website: www.idexx.com
Sector: Health Care
Industry: Life Sciences Tools & Services

IDXX - Idexx Laboratories Inc

About Idexx Laboratories Inc

IDXX Key Statistics

How IDXX Compares to Peers

Idexx Laboratories Inc Company Information

IDXX Lician Score

IDXX Financial Snowflake

Upcoming Events for IDXX